
Corporate
Rezdiffra Hits $958M in Year One — But Madrigal Stock Drops 11%
Feb 19
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for MADRIGAL PHARMACEUTICALS.
Feb 19, 2026
Nov 4, 2025
Aug 5, 2025
May 1, 2025
Feb 26, 2025
Oct 31, 2024
Aug 7, 2024
May 7, 2024